Efficacy of Short-course Blinatumomab for MRD Erradication in B-ALL
- Status
- RECRUITING
- Phase
- PHASE2
Clinical Trials Related to Acute Lymphoblastic Leukemia
Related studies linked through entity extraction aliases.
A 3-cohort Randomized Study Evaluating the Role of New Immunotherapeutic Agents and of Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) in Frontline Therapy of Adults With Acute Lymphoblastic Leukemia
- Status
- RECRUITING
- Phase
- PHASE2/PHASE3
Newly-diagnosed Pediatric T-cell ALL Protocol
- Status
- RECRUITING
- Phase
- PHASE2/PHASE3
CAR T CELL Therapy for Pediatric, Adolescent and Young Adult Patients With CD19-Positive Leukemia
- Status
- RECRUITING
- Phase
- PHASE2
Study on the Efficacy and Safety of the TmBU Conditioning Regimen in High-risk or Relapsed/Refractory Acute Leukemia
- Status
- RECRUITING
- Phase
- PHASE2
Vedolizumab Plus Post-transplant Cyclophosphamide and Short Course Tacrolimus for the Prevention of Graft Versus Host Disease in Patients Undergoing Allogeneic Hematopoietic Cell Transplantation After Reduced Intensity Conditioning
- Status
- RECRUITING
- Phase
- PHASE2
Effects of Core Stabilization Exercises in Children with Acute Lymphoblastic Leukemia
- Status
- RECRUITING
- Phase
- NA
CD19-CD22-Bispecific Chimeric Antigen Receptor (CAR) T Cell Therapy for Pediatric Patients With Acute Lymphoblastic Leukemia
- Status
- RECRUITING
- Phase
- PHASE1
Inaticabtagene Autoleucel (Inati-cel; CNCT19) Treatment for Newly Diagnosed B-cell ALL Patients in CR1
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Preventing of GVHD with Post-transplantation Cyclophosphamide, Abatacept, Vedolizumab and Ruxolitinib At Children and Young Adults with Hemoblastosis
- Status
- RECRUITING
- Phase
- PHASE2/PHASE3
CD19/CD22 CAR-T Cell Therapy in MRD-Positive B-lineage Acute Lymphoblastic Leukemia in Children.
- Status
- RECRUITING
- Phase
- PHASE1
Allogeneic CMV-Specific CD19-CAR T Cells Plus CMV-MVA Triplex Vaccine After Matched Related Donor Hematopoietic Cell Transplant for the Treatment of Patients With High-Risk Acute Lymphoblastic Leukemia
- Status
- RECRUITING
- Phase
- EARLY_PHASE1
Inaticabtagene Autoleucel (Inati-cel; CNCT19) Treatment for MRD-Positive B-ALL Patients in CR1
- Status
- RECRUITING
- Phase
- PHASE2
Systemic Inflammation Response Index and C-Reactive Protein to Albumin Ratio in Acute Lymphoblastic Leukemia
- Status
- NOT_YET_RECRUITING
- Phase
- N/A
Effects of Home-Based Exercise Program in Children After Acute Lymphoblastic Leukemia
- Status
- COMPLETED
- Phase
- NA
Safety and Efficacy of PRG-2302 for Refractory or Relapsed B-cell Acute Lymphoblastic Leukemia Disease.
- Status
- RECRUITING
- Phase
- EARLY_PHASE1
A Study of Different Programs to Help ALL Patients With Taking Maintenance Medicine at Home
- Status
- SUSPENDED
- Phase
- NA
Revumenib for the Treatment of Acute Leukemia in Patients Post-Allogeneic Stem Cell Transplant
- Status
- RECRUITING
- Phase
- PHASE1
Therapy for Newly Diagnosed Patients With B-Cell Precursor Acute Lymphoblastic Leukemia and Lymphoma
- Status
- RECRUITING
- Phase
- PHASE2
Vitamin A and D Supplementation in Allogeneic HCT
- Status
- RECRUITING
- Phase
- PHASE2